Literature DB >> 32412644

Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.

Faraz Ali1, Jui Vyas, Andrew Y Finlay.   

Abstract

Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The burden of atopic dermatitis on children and adults is extensive and there is also significant impact on the lives of patient caregivers and family members. It is important to be able to measure this impact to inform clinical decisions and to plan appropriate patient and carer support. The current impact of atopic dermatitis on children and adults can be measured using several different quality of life questionnaires: the most frequently used are the Dermatology Quality of Life (DLQI), Children's Dermatology Quality of Life and Infants Dermatology Quality of Life. The impact on partners and family can be measured using several atopic dermatitis specific questionnaires or the Family DLQI or the generic Family Reported Outcome Measure, FROM-16.

Entities:  

Keywords:  atopic dermatitis; dermatitis; quality of life; eczema

Mesh:

Year:  2020        PMID: 32412644      PMCID: PMC9189752          DOI: 10.2340/00015555-3511

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  124 in total

Review 1.  A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.

Authors:  F M Ali; A C Cueva; J Vyas; A A Atwan; M S Salek; A Y Finlay; V Piguet
Journal:  Br J Dermatol       Date:  2016-10-12       Impact factor: 9.302

2.  The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire.

Authors:  V Lawson; M S Lewis-Jones; A Y Finlay; P Reid; R G Owens
Journal:  Br J Dermatol       Date:  1998-01       Impact factor: 9.302

3.  A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics.

Authors:  Yik Weng Yew; Jacob P Thyssen; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2018-10-01       Impact factor: 11.527

4.  Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Authors:  J R Chalmers; K S Thomas; C Apfelbacher; H C Williams; C A Prinsen; P I Spuls; E Simpson; L A A Gerbens; M Boers; S Barbarot; J F Stalder; K Abuabara; V Aoki; M Ardeleanu; J Armstrong; B Bang; T L Berents; T Burton; L Butler; T Chubachi; A Cresswell-Melville; A DeLozier; L Eckert; L Eichenfield; C Flohr; M Futamura; A Gadkari; E S Gjerde; K F van Halewijn; C Hawkes; L Howells; L Howie; R Humphreys; H A Ishii; Y Kataoka; I Katayama; W Kouwenhoven; S M Langan; Y A Leshem; S Merhand; P Mina-Osorio; H Murota; T Nakahara; F P Nunes; U Nygaard; M Nygårdas; Y Ohya; E Ono; E Rehbinder; N K Rogers; G L E Romeijn; M L A Schuttelaar; A V Sears; M A Simpson; J A Singh; J Srour; B Stuart; Å Svensson; G Talmo; H Talmo; H D Teixeira; J P Thyssen; G Todd; F Torchet; A Volke; L von Kobyletzki; E Weisshaar; A Wollenberg; M Zaniboni
Journal:  Br J Dermatol       Date:  2018-04-19       Impact factor: 9.302

5.  The family impact of skin diseases: the Greater Patient concept.

Authors:  M K A Basra; A Y Finlay
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

6.  Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study.

Authors:  K Moore; T J David; C S Murray; F Child; P D Arkwright
Journal:  Br J Dermatol       Date:  2006-03       Impact factor: 9.302

7.  Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index: evidence of equivalence.

Authors:  F M Ali; N Johns; A Y Finlay; M S Salek; V Piguet
Journal:  Br J Dermatol       Date:  2017-06-12       Impact factor: 9.302

8.  The significance of structured parental educational intervention on childhood atopic dermatitis: a randomized controlled trial.

Authors:  N Pustišek; M Šitum; M Vurnek Živković; S Ljubojević Hadžavdić; M Vurnek; T Niseteo
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-11-30       Impact factor: 6.166

Review 9.  Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.

Authors:  M S Salek; S Jung; L A Brincat-Ruffini; L MacFarlane; M S Lewis-Jones; M K A Basra; A Y Finlay
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

10.  Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine.

Authors:  Z U Bhatti; A Y Finlay; C E Bolton; L George; J P Halcox; S M Jones; R I Ketchell; R H Moore; M S Salek
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-10-18       Impact factor: 6.166

View more
  7 in total

1.  Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.

Authors:  Trinidad Montero-Vilchez; Juan-Angel Rodriguez-Pozo; Pablo Diaz-Calvillo; Maria Salazar-Nievas; Jesús Tercedor-Sanchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

Review 2.  Probiotics Function in Preventing Atopic Dermatitis in Children.

Authors:  Caterina Anania; Giulia Brindisi; Ivana Martinelli; Edoardo Bonucci; Miriam D'Orsi; Sara Ialongo; Anna Nyffenegger; Tonia Raso; Mattia Spatuzzo; Giovanna De Castro; Anna Maria Zicari; Carlo Carraro; Maria Grazia Piccioni; Francesca Olivero
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

3.  Recruitment of adults with moderate eczema for a randomised trial: Comparison of traditional versus modern methods.

Authors:  Fabrizio Spada; Ian P Harrison; Tanya M Barnes; Kerryn A Greive; Daisy Daniels; Joshua P Townley; Niyaz Mostafa; Andrew T Fong; Philip L Tong; Stephen Shumack
Journal:  Australas J Dermatol       Date:  2021-09-03       Impact factor: 2.481

Review 4.  Skin Dialogues in Atopic Dermatitis.

Authors:  Elena Porumb-Andrese; Claudia Florida Costea; Andrei Cucu; Gabriela Rusu-Zota; Daciana Elena Braisteanu; Vlad Porumb; Mihaela Monica Scutariu; Alexandra Maria Dorobanțu; Ramona Gabriela Ursu
Journal:  Diagnostics (Basel)       Date:  2022-08-04

5.  Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study.

Authors:  Maddalena Napolitano; Gabriella Fabbrocini; Iria Neri; Luca Stingeni; Valeria Boccaletti; Vincenzo Piccolo; Giuseppe Fabrizio Amoruso; Giovanna Malara; Rocco De Pasquale; Eugenia Veronica Di Brizzi; Laura Diluvio; Luca Bianchi; Andrea Chiricozzi; Adriana Di Guida; Elisabetta Del Duca; Viviana Moschese; Vito Di Lernia; Federica Dragoni; Michaela Gruber; Katharina Hansel; Amelia Licari; Sara Manti; Salvatore Leonardi; Luca Mastorino; Michela Ortoncelli; Eugenio Provenzano; Antonino Palermo; Vincenzo Patella; Tiziana Peduto; Elena Pezzolo; Viviana Piras; Luca Potestio; Teresa Battista; Rosanna Satta; Stefania Termine; Paolo Palma; Paola Zangari; Cataldo Patruno
Journal:  Paediatr Drugs       Date:  2022-08-27       Impact factor: 3.930

6.  National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis.

Authors:  Niccolò Gori; Andrea Chiricozzi; Franco Marsili; Silvia Mariel Ferrucci; Paolo Amerio; Vincenzo Battarra; Salvatore Campitiello; Antonio Castelli; Maurizio Congedo; Monica Corazza; Antonio Cristaudo; Gabriella Fabbrocini; Giampiero Girolomoni; Giovanna Malara; Giuseppe Micali; Giovanni Palazzo; Aurora Parodi; Annalisa Patrizi; Giovanni Pellacani; Paolo Pigatto; Eugenio Provenzano; Pietro Quaglino; Marco Romanelli; Mariateresa Rossi; Paola Savoia; Ketty Peris
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

7.  Atopic Dermatitis Severity, Patient Perception of the Disease, and Personality Characteristics: How Are They Related to Quality of Life?

Authors:  Liborija Lugović-Mihić; Jelena Meštrović-Štefekov; Iva Ferček; Nives Pondeljak; Elvira Lazić-Mosler; Ana Gašić
Journal:  Life (Basel)       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.